N-ethylmaleimide increases P-glycoprotein photoaffinty labeling with iodoaryl-azidoprazosin in multidrug resistant cells

Anticancer Research

Volumn 17, Issue 1 A, 1997, Pages 357-364

  Wang, Ying ^a   Georges, Elias ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Multidrug resistance; N ethylmaleimide; P glycoprotein; Phosphorylation; Photoaffinity

Indexed keywords

ADENOSINE TRIPHOSPHATASE; BACTERIAL PROTEIN; CALYCULIN A; CYSTEINE; GLYCOPROTEIN P; IODOARYLAZIDOPRAZOSIN; LIPOSOME; N ETHYLMALEIMIDE; PRAZOSIN; UNCLASSIFIED DRUG; VINBLASTINE;

ARTICLE; CELL MEMBRANE; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; DRUG EFFECT; ENZYME INHIBITION; HUMAN; HUMAN CELL; MULTIDRUG RESISTANCE; PHENOTYPE; PHOTOAFFINITY LABELING; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION;

AFFINITY LABELS; ANIMALS; AZIDES; CELL LINE; CRICETINAE; CRICETULUS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, MULTIPLE; ETHYLMALEIMIDE; P-GLYCOPROTEIN; PHOSPHORYLATION; PRAZOSIN;

EID: 0031050256     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Gottesman MM and Pastan I: Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem 62: 385-427, 1993.
2. Endicott JA and Ling V: The biochemistry of P-glycoprotein-mediated multidrug resistance. Annu Rev Biochem 58: 137-171, 1989.
3. Higgins CF: The ABC of channel regulation. Cell 82: 693-6, 1995.
4. Cole SP, Sparks KE, Fraser K, Loe DW, Grant CE, Wilson GM and Deeley RG: Pharmacological characterization of multidrug resistant MRP-transfected human tumour cells. Cancer Res 54: 5902-5910, 1994.
5. Riordan JR: The cystic fibrosis transmembrane conductance regulator. Annu Rev Physiol 55: 609-630, 1993.
6. McGrath JP and Varshavsky A: The yeast STE6 gene encodes a homologue of the mamalian multidrug resistance P-glycoprotein: Nature 340: 400-404, 1989.
7. Ng WF, Sarangi F, Zastawny R, Veinot-Drebot L and Ling V: Identification of members of the Pglycoprotein multigene family. Mol Cell Biol 9: 1224-1232, 1989.
8. Dhir R, Buschman E und Gros P: Structural and functional characterization of the mouse Multidrug resistance gene Family. Bull de Cancer 77: 1125- 1129, 1990.
9. Devault A and Gros P: Two members of the mouse mdr gene family confer multidrug resistance with overlapping but distinct drug specificities. Mol Cell Biol 10: 1652-1663, 1990.
10. Buschman, E and Gros P: The inability of the mouse mdr2 gone to confer multidrug resistance is linked to reduced drug binding to the protein. Cancer Res 54: 4892-4893, 1994.
11. Schinkel AH, Roelofs MEM and Borst P: Characterization of the human MDR3 P-glycoprotein and its recognition by P-glycoprotein-specific monoclonal antibodies. Cancer Res 51: 2628-2635, 1991.
12. Shapiro AB and Ling V: ATPase activity of purified and reconstituted P-glycoprotein from Chinese hamster ovary cells. J Biol Chem 269: 3745-3754, 1994.
13. Doige CA, Yu, X and Sharom FJ: ATPase activities of partially purified P glycoprotein from multidrug resistant Chinese hamster ovary cells. Biochem Biophys Acta 1109: 149-160, 1992.
14. Ambudkar SV, Lelong IH, Zhang J, Cardarelli CO, Gottesman MM and Pastan I: Partial purification and reconstitution of the human multidrug resistance pump: Characterization of drug-stimulate ATP hydrolysis. Proc Natl Acad Sci (USA) 89: 8472-8476, 1992.
15. Georges E, Sharom FJ and Ling V: Multidrug resistance and chemosensitization: therapeutic implications for cancer chemotherapy. Adv Pharmacol 21: 185-220, 1990.
16. Nielson D and Svovsgaard T: P-glycoprotein as multidrug transporter: a critical review of current multidrug resistant cell lines. Biochem Biophys Acta 1139: 169-183, 1992.
17. Sarkadi B, Muller M, Homolya L, Hollo Z, Seprodi J, Germann UA, Gottesman MM, Price EM and Bouche RC: Interaction of bioactive hydrophobic peptides with the human multidrug transporter. FASEB J 8: 766-770, 1994.
18. Abraham EH, Prat AG, Gerweck L, Seneveratne T, Arcei RJ, Kramer R, Guidotti G and Cantiello HF: The multidrug resistance (mdr1) gene product functions as an ATP channel. Proc Natl Acad Sci (USA) 90: 312-316, 1993.
19. Greenberger LM: Major photoaffinity labelling sites for iodoaryl azidoprazosin in Pglycoprotein are within, or immediately C-terminal to, transmembrane domain 6 and 12. J Biol Chem 268: 11417- 11425, 1993.
20. Raviv Y, Pollard HB, Bruggemann EP, Pastan I and Gottesman MM: Photosensitized labelling of a functional multidrug transporter in living drug-resistant tumour cells. J Biol Chem 265: 3975-3980, 1990.
21. Zordan-Nudo T, Ling V, Liu Z and Georges E: Effects of nonionic detergents on P-glycoprotein drug binding and reversal of multidrug resistance. Cancer Res 53: 5994-6000, 1993.
22. Loe DW and Sharom FJ: Interaction of multidrug-resistant Chinese hamster ovary cells with amphiphiles. British J Cancer 68: 342-351, 1993.
23. Dhir R, Grizzuti K, Kajiji S and Gros P: Modulatory effects on substrate specificity of independent mutations at the serine 939/941 position in predicted transmembrane domain 11 of P-glycoprotein. Biochemistry 32: 9492-9499, 1993.
24. Loo TW and Clarke DM: Functional consequences of phenylalanine mutations in the predicted transmembrane domain in P-glycoprotein. J Biol Chem 268: 19965-19972, 1993.
25. Loo TW and Clarke DM: Mutations to amino acids located in predicted transmembrane segment 6 (TM6) modulate the activity and substrate specificity of human P-glycoprotein. Biochemistry 33: 14049-14057, 1994.
26. Devine SE Ling V and Melera PW: Amino acid substitutions in the sixth transmembrane domain of P-giycoprotein alter multidrug resistance. Proc Natl Acad Sci (USA) 89: 4564-4568, 1992.
27. Higgins CF: Filp-Flop: the transmembrane translocation of lipids. Cell 79: 393-395, 1994.
28. Azzaria M, Schurr E and Gros P: Discrete mutations introduced in the predicted nucleotide binding sites of mdrl gene abolish its ability to confer multidrug resistance. Mol Cell Biology 9: 5289-5297, 1989.
29. Georges E, Zhang JT and Ling V: Modulation of ATP and drug binding by monoclonal antibodies against P-glycoprotein. J Cell Phsiol 148: 479-484, 1991.
30. Al-Shawi MK and Senior AE: Characterization of the adenosine triphosphatase activity of Chinese hamster P-glycoprotein. J Biol Chem 268: 4197-4206, 1993.
31. Feng Y and Forgac M: Inhibition of vacuolar H (+)-ATP ase by disulfide bond formation between cysteine 254 and cysteine 532 in subunit A. J Biol Chem 269: 13224-13230, 1994.
32. Dayan G, Baubichon-Cortay H, Jault J-M, Cortay J-C, Deleage G and Di Pietro A: Recombinant N-terminal nucleotide-binding domain from mouse P-glycoprotein. J Biol Chem 271: 11652-11658, 1996.
33. Lin PH, Selinfreund R, Wakshull E and Wharton W: Rapid and efficient purification of plasma membrane from cultured cells: characterization of epidermal growth factor binding. Biochemistry 26: 731-736, 1987.
34. Lowry OH, Rosenbrough NJ, Farr AL and Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275, 1951.
35. Kartner N, Evernden-Porelle D, Bradely G and Ling V: Detection of P glycoprotein in multidrug resistant cell lines by monoclonal antibodies. Nature (Lond.) 316: 820-823, 1985.
36. Cleveland DW, Fischer SG, Kirschner MW and Laemmli UK: Peptide mapping by limited proteolysis in sodium dodecyl sulfate and analysis by gel electrophoresis. J Biol Chem 252: 1102- 1106, 1977.
37. Fairbanks G, Steck TL and Wallach DFH: Electrophoretic analysis of the major polypepetides of the human erythrocyte membrane. Biochemistry 10: 2606-2617, 1971.
38. Towbin H, Staehelin T and Gordon J: Electrophoretic transfer of proteins from polyacrylaminde gels to nitrocelluloses sheets: procedure and some applications. Proc Natl Acad Sci (USA) 76: 4350-4354, 1979.
39. Beck WT: Vinca alkaloid-resitant phenotype in cultured human leukemic Iymphoblasts. Cancer Treat Rep 67: 875-882, 1983.
40. Loo TW and Clarke DM: Membrane topology of a cysteine-less mutant of human P-glycoprotein. J Biol Chem 270: 843-848, 1995.
41. Greenberger LM: Major photoaffinity drug labelling sites for iodoaryl azidoprozosin in Pglycoprotein are within, or immediatedly C-terminal to, transmembrane domain 6 and 12. J Biol Chem 268: 11417-11425, 1993.
42. Gros P, Dhir R, Croop J and Talbot F: A single amino acid substitution strongly modulates the actvity and substrate specificity of the mouse mdrl and mdr3 drug efflux pumps. Proc Natl Acad Sci (USA) 88: 7289-7293, 1991,
43. Wright JK, Dornmair K, Mitaku S, Moroy T, Neuhaus JM, Seckler R, Vogel H, Weigel U, Jahnig F, Overath P: Lactose: H+ carrier of Escherichia coli: kinetic mechanism, purification, and structure. Annals of the New York Academy of Sciences 456: 326-341, 1985.
44. Morris DI, Greenberger LM, Bruggemann EP, Cardarelli C, Gottesman MM, Pastan I and Seamon KB: Localization of the forskolin labelling sites to both halves of P-glycoprotein: similarity of the sites labeled by forskolin and prazosin. Mol Pharmacol 46: 329-337, 1994.
45. Chambers TC, Pohl J, Raynor RL and Kuo JF: Identification of specific sites in human Pglycoprotein phosphorylated by protein kinase C. J Biol Chem 268: 4592-4595.
46. Fine RL, Patel J and Chabner BA: Phorbol easier induce multidrug resistance in human breast cancer cells. Proc Natl Acad Sci (USA) 85: 582-586, 1988.
47. Bates SE, Currier SJ, Alcarez M and Fojo T: Modulation of P-glycoprotein phosphorylation and drug transport by soduim butyrate. Biochemistry 31: 6366-6372, 1992.
48. Marsh W and Center MS: Evidence for the involvement of two distinct membrane proteins in adriamycin resistance in Chinese hamster lung cells. Cancer Res 45: 6088-6092, 1985.
49. Chambers TC, Zheng B, Kuo JF: Regulation by phobol ester and protein kinase C inhibitors, and by a protein phosphatase inhibotor (Okadic acid), of P-glycoprotein phosphoryiation and relationship to drug accumulation in multidrug resistance human KB cells. Mol Pharmacology 41: 1008-1015, 1992.
50. Germann UA, Chambers TC, Ambudkar SV, Licht T, Cardarelli CO, Pastan I and Gottesman MM: Characterization of phosphoryaltion-defective mutants of human P-glycoprotein expressed in mamalian cells. J Biol Chem 271: 1708-1716, 1996.